News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News The Smartphone Will See You Now: Clinical Research Can Be Done via App Yael L. Maxwell December 16, 2016
News Daily News Pérdidas Lipídicas: Datos a Nivel Nacional Revelan Descensos Drásticos de Colesterol Total, Triglicéridos y LBD Yael L. Maxwell November 30, 2016
News Daily News Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL Yael L. Maxwell November 30, 2016
News Conference News AHA 2016 En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 “Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients Yael L. Maxwell November 21, 2016
News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’ Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
News Daily News Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell November 11, 2016
News Daily News Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias Yael L. Maxwell November 11, 2016
News Daily News Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In Yael L. Maxwell November 10, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016